This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Dec;64(6):2324-5.

doi: 10.1046/j.1523-1755.2003.341_4.x.

Calcimetic AMG 073 at 50 and 100 mg per day

Janette Mansour, Mohamed Benyahia, Leid Harbouche, Claire Presne, Philippe Moriniere, Albert Fournier

PMID: 14633162
DOI: 10.1046/j.1523-1755.2003.341_4.x

Free article

Comment

Calcimetic AMG 073 at 50 and 100 mg per day

Janette Mansour et al. Kidney Int. 2003 Dec.

Free article

. 2003 Dec;64(6):2324-5.

doi: 10.1046/j.1523-1755.2003.341_4.x.

Authors

Janette Mansour, Mohamed Benyahia, Leid Harbouche, Claire Presne, Philippe Moriniere, Albert Fournier

PMID: 14633162
DOI: 10.1046/j.1523-1755.2003.341_4.x

No abstract available

PubMed Disclaimer

Comment on

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ. Lindberg JS, et al. Kidney Int. 2003 Jan;63(1):248-54. doi: 10.1046/j.1523-1755.2003.00720.x. Kidney Int. 2003. PMID: 12472790 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- ClinicalTrials.gov